JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 6 December 2006
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01967-06v1
81/4/1848    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagata, N.
Right arrow Articles by Sata, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagata, N.
Right arrow Articles by Sata, T.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01967-06
Copyright (c) 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Participation of both host and virus factors in induction of severe acute respiratory syndrome in F344 rats infected with SARS coronavirus

Noriyo Nagata*, Naoko Iwata, Hideki Hasegawa, Shuetsu Fukushi, Masaru Yokoyama, Ayako Harashima, Yuko Sato, Masayuki Saijo, Shigeru Morikawa, and Tetsutaro Sata

Departments of Pathology and Virology I, and Center for Pathogen Genomics National Institute of Infectious Diseases, Tokyo, Japan

* To whom correspondence should be addressed. Email: nnagata{at}nih.go.jp,


   Abstract

To understand the pathogenesis and develop an animal model of severe acute respiratory syndrome-associated coronavirus (SARS-CoV), the Frankfurt 1 SARS-CoV isolate was passaged serially in young F344 rats. Young rats were susceptible to SARS-CoV, but cleared the virus rapidly within 3 to 5 days of intranasal inoculation. After 10 serial passages, replication and virulence of SARS-CoV were increased in the respiratory tract of young rats without clinical signs. By contrast, adult rats infected with the passaged virus showed respiratory symptoms and severe pathological lesions in the lung. Levels of inflammatory cytokine in sera and lung tissues were significantly higher in adult F344 rats than in young rats. During in vivo passage of SARS-CoV, a single amino acid substitution was introduced within the binding domain of the viral spike protein recognizing angiotensin-converting enzyme 2 (ACE2), known as a SARS-CoV receptor. The rat-passaged virus more efficiently infected CHO cells expressing rat ACE2 compared to the original isolate. These results strongly indicate that host and virus factors such as respective advance age and virus adaptation are critical for development of SARS in rats.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.